Valtya 1/50 Kit
Product Images NDC 70700-305

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valtya 1/50 (NDC 70700-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fc14b90c 31f3 4f1e B31f 00fa4c81cf96 01)

Structure (Fc14b90c 31f3 4f1e B31f 00fa4c81cf96 01)
Chemical structure of ethynodiol diacetate, the active ingredient in VALTYA 1/50. The molecular weight is indicated as 384.51. The diagram shows the steroid backbone with attached acetate and ethynyl functional groups.*
FDA Label Image

Structure (Fc14b90c 31f3 4f1e B31f 00fa4c81cf96 02)

Structure (Fc14b90c 31f3 4f1e B31f 00fa4c81cf96 02)
Chemical structure of ethinyl estradiol with a molecular weight of 296.41, shown as a labeled structural formula diagram.*
FDA Label Image

Graph (Fc14b90c 31f3 4f1e B31f 00fa4c81cf96 03)

Graph (Fc14b90c 31f3 4f1e B31f 00fa4c81cf96 03)
A bar chart displaying mortality rates per 100,000 woman-years across different age groups (15-24, 25-34, 35-44, 45 and older). The chart compares four groups: ever-users non-smokers, ever-users smokers, controls non-smokers, and controls smokers, with mortality rates increasing notably in the oldest age group for ever-users who smoke.*
FDA Label Image

Blister (Fc14b90c 31f3 4f1e B31f 00fa4c81cf96 05)

Blister (Fc14b90c 31f3 4f1e B31f 00fa4c81cf96 05)
VALTYA 1/50 tablet kit label showing a 28-day pill schedule arranged by week and day with day markers from Sunday to Saturday. The label differentiates 21 orange active pills and 7 green reminder pills. It includes the full generic name ethynodiol diacetate and ethinyl estradiol with strengths of 1 mg/50 mcg, and storage instructions at room temperature. The labeler is Xiromed LLC with NDC 70700-305.*
FDA Label Image

Figure 2. Risk Of Breast Cancer With Combined Oral Contraceptive Use (Image 01)

Figure 2. Risk Of Breast Cancer With Combined Oral Contraceptive Use (Image 01)
A forest plot chart showing effect estimates (OR/RR) with confidence intervals from various studies, including NICHD Women's Contraceptive Study (2002), French E3N cohort Study (2005), Shanghai Women's Health Study (2009), The Nurses' Health Study II (2010), Oxford Family Planning Association Study (2013), and Danish Sex Hormone Register Study (2017). The horizontal axis represents the effect estimate scale ranging from approximately -1.5 to 2, with points and error bars illustrating the risk ratios and confidence intervals for current and ever use.*
FDA Label Image

3s Carton (Image 02)

3s Carton (Image 02)
Packaging label for VALTYA 1/50 kit containing tablets with ethynodiol diacetate 1 mg and ethinyl estradiol 50 mcg. The label indicates 3 pouches, each containing one blister pack of 28 tablets. Manufactured by Xiromed LLC, the label also includes the NDC 70700-305 and highlights that this is a prescription drug (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.